Related Experiment Video

Updated: Jun 28, 2026

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System
11:31

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

Published on: August 8, 2012

A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysis

Rikke Baek Sørensen1, Inge Marie Svane, Per Thor Straten

  • 1Centre for Cancer Immune Therapy (CCIT), Department of Hematology, Herlev University Hospital, Herlev, Denmark.

Cancer Biology & Therapy
|October 18, 2008
PubMed

Insights

Researchers isolated a survivin-specific cytotoxic T lymphocyte (CTL) clone that effectively targets various cancer cells. This finding supports survivin as a universal antigen for effective cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Survivin is overexpressed in many cancers, essential for tumor cell survival, and poorly expressed in normal tissues.
  • Survivin-specific immune responses exist in cancer patients, but prior studies lacked specific T-cell clones for tumor lysis.

Purpose of the Study:

  • To isolate and expand a survivin-specific cytotoxic T lymphocyte (CTL) clone.
  • To evaluate the efficacy of this CTL clone against a panel of diverse cancer cells.

Main Methods:

  • Isolation and expansion of a survivin-specific CTL clone from a cancer patient's peripheral blood.
  • Assessment of the CTL clone's ability to lyse various tumor cell lines (breast, colon, melanoma).

Main Results:

  • A survivin-specific CTL clone was successfully isolated and expanded.
  • The CTL clone demonstrated efficient lysis of multiple cancer cell types, including breast, colon, and melanoma.
  • The results validate survivin as a potential universal target antigen.

Conclusions:

  • Survivin-specific CTL clones can be generated from cancer patients.
  • Survivin represents a promising universal target antigen for developing novel cancer immunotherapies.

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...